All In Biotech

Drug Trial Radar · NCT05536804

A Study of Tirzepatide (LY3298176) in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes

Tirzepatide Study of Renal Function in People With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes: Focus on Kidney Hypoxia in Relation to Fatty Kidney Disease Using Multiparametric Magnetic Resonance Imaging

Last checked: Nov 20, 2026Latest source record: Sep 11, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 134 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

134

Actual

Start

Feb 8, 2023

Primary completion

Jul 6, 2026

Study completion Jul 30, 2026

Sponsor

Lead sponsor
Eli Lilly and CompanyEli Lilly (LLY)
Sponsor type
Industry
First posted
Sep 13, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

We are doing this study to learn more about how tirzepatide may help fight chronic kidney disease in people with obesity with or without type 2 diabetes (T2D). The study will last about 56 weeks and include up to 12 visits.

Conditions

  • Overweight
  • Obesity
  • Chronic Kidney Disease
  • Type 2 Diabetes
  • T2D

Interventions

  • TirzepatideDrug

    Administered SC

  • PlaceboDrug

    Administered SC

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percent Change from Baseline in Renal Sinus Fat Content (MRI)Time frame: Baseline, Week 52

Locations

27 sites in 6 countries. Site status is shown where the registry gives one.

  • Valley Clinical Trials, Inc.

    Northridge, California

  • University of Colorado Anschutz Medical Campus

    Aurora, Colorado

  • Kidney Associates of Colorado

    Denver, Colorado

  • American Health Network of Indiana, LLC - Avon

    Avon, Indiana

  • American Health Network of Indiana, LLC - Greenfield

    Greenfield, Indiana

  • Indiana University Health University Hospital

    Indianapolis, Indiana

  • American Health Network of Indiana, LLC - Muncie

    Muncie, Indiana

  • Arcturus Healthcare , PLC, Troy Internal Medicine Research Division

    Troy, Michigan

  • University of Washington Medical Center - Montlake

    Seattle, Washington

  • Providence Medical Research Center - Spokane

    Spokane, Washington

  • Klinik Landstraße

    Vienna, Austria

  • Zentrum für klinische Studien Dr Hanusch Gmbh

    Vienna, Austria

  • Klinik Hietzing

    Vienna, Austria

  • LMC Clinical Research Inc. (Barrie)

    Barrie, Canada

  • LMC Clinical Research Inc. (Thornhill)

    Concord, Canada

  • Centre intégré universitaire de santé et de services sociaux de l'Estrie Centre Hospitalier Universitaire -T

    Sherbrooke, Canada

  • Toronto General Hospital

    Toronto, Canada

  • Fadia El Boreky Medicine

    Waterloo, Canada

  • Aarhus Universitetshospital, Skejby

    Aarhus, Denmark

  • Centro de Investigación y Gastroenterología

    Cuauhtémoc, Mexico

  • Investigación Nefrológica

    Cuernavaca, Mexico

  • Instituto Nacional de Cardiologia Ignacio Chavez

    México, Mexico

  • Health Pharma Professional Research S.A. de C.V:

    Mexico City, Mexico

  • Grupo Medico Camino Sc

    Mexico City, Mexico

  • Caimed Investigacion En Salud S.A. de C.V.

    Mexico City, Mexico

  • Ziekenhuisgroep Twente, locatie Almelo

    Almelo, Netherlands

  • Amsterdam UMC, locatie VUmc

    Amsterdam, Netherlands

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.